Noonan K J, Leyes M, Forriol F, Cañadell J
Department of Orthopaedic Surgery, Clinica Universitaria, School of Medicine, University of Navarra, Pamplona, Spain.
J Bone Joint Surg Am. 1998 Jun;80(6):793-806. doi: 10.2106/00004623-199806000-00003.
We reviewed the results of distraction osteogenesis of 114 femora and 147 tibiae that had been lengthened to treat a variety of diagnoses. The femora had been lengthened an average of eleven centimeters (range, 3.5 to 17.0 centimeters), or 48 per cent (range, 8 to 86 per cent) of the original femoral length. The average total time for the treatment of the femora (use of the fixator and any subsequent immobilization) was 257 days (range, 105 to 420 days). There were 114 complications related to the femoral lengthenings, which led to eighty-seven additional operations. The tibiae were lengthened an average of nine centimeters (range, 3.0 to 15.6 centimeters), or 41 per cent (range, 9 to 100 per cent) of the original tibial length. The average total time for the treatment of the tibiae was 268 days (range, 110 to 497 days). There were 196 complications related to the tibial lengthenings, which led to 219 additional operations. The Achilles tendon was lengthened during or after seventy-three (50 per cent) of the tibial lengthenings. The femoral lengthenings that were performed to treat a limb-length discrepancy were associated with significantly higher rates of complications overall (p = 0.010) and additional operations (p = 0.023) for each percentage of length gained than those that were performed to treat achondroplasia or another skeletal dysplasia. The femoral lengthenings that were performed to treat short stature (of an endocrine or idiopathic etiology) were also associated with higher rates of complications overall and additional operations than those performed to treat skeletal dysplasias, but the rates were lower than those for lengthenings performed to treat limb-length discrepancy. The rate of complications overall associated with femoral lengthening in patients who were fourteen years old or more was significantly higher than that associated with lengthening in patients who were less than fourteen years old (p = 0.047). Femoral lengthening through the metaphysis was associated with significantly higher rates of complications overall (p = 0.031) and additional operations (p = 0.042) for each percentage of length gained than femoral lengthening through the diaphysis. The tibial lengthenings that were performed to treat Turner syndrome and idiopathic short stature were associated with significantly higher rates of complications overall (p = 0.026) and additional operations (p = 0.003) for each percentage of length gained than those performed to treat skeletal dysplasias. The rate of joint-related problems (p = 0.044) and that of additional operations (p = 0.053) after tibial lengthening in patients who were fourteen years old or more were significantly higher than those rates after tibial lengthening in patients who were less than fourteen years old. The site of the tibial osteotomy did not affect the rate of complications or additional operations. The femoral healing indices (in terms of both days per centimeter [p = 0.002] and days for each percentage of length gained [p = 0.019]) were significantly higher in the patients who were fourteen years old or more than in those who were less the fourteen years old. These values could not be used to predict an increase in the complications because of poor bone formation. The results of the present review suggest that the use of healing indices to gauge the final outcome of distraction osteogenesis is questionable; we were unable to discern significance or clinical importance from appropriately adjusted values.
我们回顾了114例股骨和147例胫骨牵张成骨的结果,这些患者因各种诊断接受了肢体延长治疗。股骨平均延长了11厘米(范围为3.5至17.0厘米),即原始股骨长度的48%(范围为8%至86%)。治疗股骨的平均总时间(使用固定器及随后的任何固定时间)为257天(范围为105至420天)。与股骨延长相关的并发症有114例,导致额外进行了87次手术。胫骨平均延长了9厘米(范围为3.0至15.6厘米),即原始胫骨长度的41%(范围为9%至100%)。治疗胫骨的平均总时间为268天(范围为110至497天)。与胫骨延长相关的并发症有196例,导致额外进行了219次手术。在73例(50%)胫骨延长手术过程中或术后进行了跟腱延长。为治疗肢体长度差异而进行的股骨延长,与为治疗软骨发育不全或其他骨骼发育异常而进行的股骨延长相比,每增加一个百分点的长度,总体并发症发生率(p = 0.010)和额外手术率(p = 0.023)显著更高。为治疗身材矮小(内分泌或特发性病因)而进行的股骨延长,与为治疗骨骼发育异常而进行的股骨延长相比,总体并发症发生率和额外手术率也更高,但低于为治疗肢体长度差异而进行的股骨延长。14岁及以上患者股骨延长的总体并发症发生率显著高于14岁以下患者(p = 0.047)。与经骨干进行股骨延长相比,经干骺端进行股骨延长,每增加一个百分点的长度,总体并发症发生率(p = 0.031)和额外手术率(p = 0.042)显著更高。与为治疗骨骼发育异常而进行的胫骨延长相比,为治疗特纳综合征和特发性身材矮小而进行的胫骨延长,每增加一个百分点的长度,总体并发症发生率(p = 0.026)和额外手术率(p = 0.003)显著更高。14岁及以上患者胫骨延长后的关节相关问题发生率(p = 0.044)和额外手术率(p = 0.053)显著高于14岁以下患者胫骨延长后的发生率。胫骨截骨部位不影响并发症发生率或额外手术率。14岁及以上患者的股骨愈合指数(以每厘米天数[p = 0.002]和每增加一个百分点长度所需天数[p = 0.019]衡量)显著高于14岁以下患者。由于骨形成不良,这些数值无法用于预测并发症的增加。本综述结果表明,使用愈合指数来评估牵张成骨的最终结果存在疑问;我们无法从适当调整后的值中辨别出其意义或临床重要性。